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Interferon antagonistThe porcine reproductive and respiratory syndrome virus nsp1 is predicted to be auto-cleaved from the
replicase polyprotein into nsp1α and nsp1β subunits. In infected cells, we detected the actual existence of
nsp1α and nsp1β. Cleavage sites between nsp1α/nsp1β and nsp1β/nsp2 were identiﬁed by protein
microsequencing analysis. Time course study showed that nsp1α and nsp1β mainly localize into the cell
nucleus after 10 h post infection. Further analysis revealed that both proteins dramatically inhibited IFN-β
expression. The nsp1β was observed to signiﬁcantly inhibit expression from an interferon-stimulated
response element promoter after Sendai virus infection or interferon treatment. It was further determined to
inhibit nuclear translocation of STAT1 in the JAK–STAT signaling pathway. These results demonstrated that
nsp1β has ability to inhibit both interferon synthesis and signaling, while nsp1α alone strongly inhibits
interferon synthesis. These ﬁndings provide important insights into mechanisms of nsp1 in PRRSV patho-
genesis and its impact in vaccine development.
© 2009 Elsevier Inc. All rights reserved.Introduction
Porcine reproductive and respiratory syndrome (PRRS), a disease
initially described in the United States in 1987 (Keffaber, 1989) and in
Europe in 1990 (Wensvoort et al., 1991), has caused tremendous
economic losses to the swine industry worldwide, with recent costs in
the United States of at least $600 million annually (Neumann, 2005).
Hallmark symptoms of PRRS are mild to severe respiratory disease in
infected newborn and growing swine, and reproductive failure in
pregnant sows. The etiologic agent, PRRSV, was ﬁrst discovered in the
Netherlands in 1991 (Wensvoort et al., 1991). In the United States,
PRRSV was ﬁrst isolated in 1992 (Benﬁeld et al., 1992; Collins et al.,
1992). Nucleotide sequence comparisons have shown that PRRSV can
be divided into distinct European (Type I) and North American (Type
II) genotypes (Allende et al., 1999; Nelsen et al., 1999).
The host innate immune response is the ﬁrst defense line to
prevent viral infection. A key aspect of the antiviral innate immune
response is the synthesis and secretion of type I interferons (IFN) such
as IFN-α and IFN-β, which exhibit antiviral, anti-proliferative and
immunomodulatory functions (reviewed by Samuel, 2001; Haller andcience and Biology/Microbio-
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ll rights reserved.Weber, 2007; Randall and Goodbourn, 2008). Two events required to
trigger an effective antiviral innate immune response are: (a) detec-
tion of the invading virus by immune system receptors; and (b)
initiation of protein signaling cascades that regulate the synthesis of
IFNs. Initially, the pathogen-associated molecular pattern in dsRNA is
recognized by host cell receptors, including Toll-like receptor 3 (TLR3),
retinoic acid-inducible protein I (RIG-I) or melanoma differentiation-
associated gene 5 (MDA5). In one dsRNA-signaling pathway, RIG-1
caspase recruitment domains associate with IFN-β promoter stimulator
1 (IPS-1) to activate the downstream kinases, such as TBK1 and IKKɛ,
resulting in the phosphorylation and activation of transcription factors,
including IRF3 and NF-kB. The coordinate activation of these transcrip-
tion factors results in the formation of a transcriptionally competent
enhanceosome that induces type I IFN production (Thanos and
Maniatis, 1995). After being secreted, type I IFN binds to their receptors
on adjacent cell surfaces to activate the so-called JAK–STAT signaling
pathway. The coupling of receptor–ligand activates JAKs (Janus
activated kinases), leading to phosphorylation of STATs (signal trans-
ducers and activators of transcription). The phosphorylated STAT1 and
STAT2, in association with IRF9, form the heterotrimeric complex
ISGF3. ISGF3 translocates to the nucleus where it binds to IFN-
stimulated response elements (ISRE) in the promoter and induces
the transcription of IFN-stimulated genes (ISGs). Activation of these
genes enables the cell to ﬁght the infection and inhibit virus replication
(Weber et al., 2004).
Fig. 1. Identiﬁcation of PRRSV nsp1 auto-cleavage products nsp1α and nsp1β in
infected cells by Western blot. MARC-145 cells were infected with SD23983 virus or
mock-infected. Viral proteins from cell lysate were separated by 15% SDS-PAGE gel and
transferred to a nitrocellulose membrane. The membrane was probed with rabbit
polyclonal anti-sera against nsp1 (pAb-nsp1) or nsp1α (pAb-nsp1α), or monoclonal
antibody against nsp1β (mAb-nsp1β). Arrows point to speciﬁc PRRSV nsp1 proteins.
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on-mediated innate immune responses against PRRSV infection. In an
earlier study, inoculation of pigs with porcine respiratory coronavirus, a
potent inducer of type I interferon, provided protection from a
subsequent PRRSV infection (Buddaert et al., 1998). Overend et al.
(2007) showed that recombinant swine IFN-β protects swine alveolar
macrophages and MARC-145 cells (a PRRSV permissive cell line) from
infection with PRRSV. Royaee et al. (2004) showed that utilizing an
expression plasmid encoding porcine IFN-α as an adjuvant resulted in a
temporary increase in the frequency of PRRSV-speciﬁc IFN-γ secreting
cells in vaccinated animals, which demonstrated an important role of
type I interferon as a link between the innate and adaptive immune
responses. However, PRRSV infection appears to elicit a poor innate
antiviral type I interferon response, which is postulated to result in a
weak adaptive immune response as demonstrated by cell-mediated
immune responses of short duration, and slow development of virus-
speciﬁc IFN-γ secreting cells leading to a prolonged viremia (Meier
et al., 2003; Royaee et al., 2004). Miller et al. (2004) showed that
stimulation of MARC-145 cells by exogenous double-stranded RNA
resulted in signiﬁcant increases in type I IFN mRNA expression, but the
double-stranded RNA induction of type I IFN activation was signiﬁ-
cantly inhibited by dual-exposure with PRRSV. Results from Luo et al
(2008) showed that PRRSV infection signiﬁcantly blocked dsRNA-
induced IFN-β production. However, little is known about the
molecular mechanism of PRRSV proteins in the regulation of interferon
activity.
PRRSV contains a single positive-stranded RNA genome, encoding
nine open reading frames. The replicase-associated genes, ORF1a and
ORF1b, are situated at the 5′ end of the genome and represent nearly
75% of the viral genome. According to the studies of the closely related
equine arteritis virus (EAV), the ORF1a-encoded replicase polyprotein
pp1a is predicted to be proteolytically cleaved into eight nonstructural
products, nsp1 to nsp8 (Snijder and Meulenberg, 1998; Allende et al.,
1999; Nelsen et al., 1999). The nsp1 contains two putative cysteine
protease domains, PCP1α and PCP1β. PCP1α was predicted to auto-
cleave between nsp1α/nsp1β, and release nsp1α from pp1a, while
PCP1βwas predicted to auto-cleave between nsp1β/nsp2, and release
nsp1β from the pp1a (den Boon et al., 1995; Snijder and Meulenberg,
1998). In a previous study, den Boon et al. (1995) identiﬁed nsp1
auto-cleaved into nsp1α and nsp1β using an in vitro translation
system. Johnson et al. (2007) showed that recombinant nsp1 protein
could be auto-catalytically processed into nsp1α and nsp1β. However,
these two cleavage products have not been identiﬁed in virus-infected
cells. More importantly, our recent study suggested that nsp1 is the
main protein antagonizing cellular production of type I interferon.
However, the detailed mechanism of how nsp1 is involved in the
inhibition of interferon production is unknown. In the present study,
we identiﬁed the nsp1α and nsp1β in virus-infected cells and deter-
mined the role of nsp1α and nsp1β in the inhibition of type I inter-
feron synthesis and signaling. The capability of PRRSV nsp1α and
nsp1β to interfere with the establishment of the innate antiviral state
suggests that these two proteins are critical virulence determinants of
PRRSV, which provides important insight into the mechanism of
PRRSV pathogenesis and future PRRSV vaccine development.
Results
Identiﬁcation of nsp1α and nsp1β in PRRSV-infected cells
Based on the study of EAV, the PRRSV nsp1 is predicted to be
cleaved into nsp1α and nsp1β subunits. Using an in vitro translation
system, den Boon et al. (1995) showed that PRRSV nsp1 was auto-
cleaved into α and β subunits of approximately 20 and 27 kDa,
respectively. These two auto-cleavage products were also obtained
when the nsp1 recombinant protein was puriﬁed from expression in
E. coli (Johnson et al., 2007). To determine if these two putativesubunits actually exist in virus-infected cells, we generated rabbit
polyclonal antiserum (pAb-nsp1, pAb-nsp1α) and a monoclonal
antibody (mAb-nsp1β) directed against the nsp1, nsp1α and nsp1β
using puriﬁed recombinant nsp1α and nsp1β proteins that were self-
cleaved products from nsp1 expression in E. coli (Johnson et al., 2007).
These antibodies were used to probe mock-infected and PRRSV
SD23983 infectedMARC-145 cells byWestern blot. As shown in Fig. 1,
from PRRSV infected cell lysate, pAb-nsp1α recognized a protein band
slightly larger than the molecular weight marker 16 kDa, which
corresponds to the predicted size of nsp1α at 20 kDa. The mAb-nsp1β
detected a sharp protein band above 22 kDamolecular weightmarker,
which corresponds to the predicted size of nsp1β at 27 kDa. Both
protein bands were detected using pAb-nsp1. These speciﬁc protein
bands were not detected in cell lysates from mock-infected cells or in
cell lysates from infected cells with pre-immune serum or negative
control mAb. This result demonstrated that the two auto-cleavage
products, nsp1α and nsp1β, actually exist in PRRSV-infected cells.
The nsp1 is located at the N-terminal of the pp1a polyprotein that
is translated with “ATG” start codon. Based on the homologous
sequence comparison between PRRSV and EAV, the Type II PRRSV
nsp1α/1β was predicted to be cleaved between 166Q↓R167, while
nsp1β/nsp2 was predicted to be cleaved between 383G↓A384 (den
Boon et al., 1995; Allende et al., 1999; Nelsen et al., 1999; Wootton et
al., 2000; Ziebuhr et al., 2000). For subsequent functional study of
each individual nsp1 protein, it is critical to elucidate the actual
cleavage sites. Therefore, we performed protein N-terminal sequenc-
ing analysis on these cleavage sites. Each individual nsp1β and nsp2
protein was immunoprecipitated from SD23983 infected cells using
speciﬁc anti-nsp1β and anti-nsp2 monoclonal antibodies. These
precipitated proteins were separated by SDS-PAGE and transferred
to a PVDF membrane. Proteins corresponding to the predicted size of
nsp1β and nsp2 were excised from PVDF membrane and subjected to
protein identiﬁcation by N-terminal sequential Edman degradation.
For nsp2 N-terminal sequence, the primary (10) major signals of the
sequence were AGRRARKARH, which is consistent with the predicted
N-terminal sequence of nsp2 at the cleavage site of 383G↓A384
(Ziebuhr et al., 2000). This cleavage site is well conserved between
Fig. 2. Comparative sequence analysis of the nsp1α/nsp1β and nsp1β/nsp2 cleavage sites. Partial ORF1a amino acid sequence of six PRRSV strains corresponding to SD23983 ORF1a
amino acid position 160–204 and 361–409 was aligned with EAV nsp1. The alignment was generated by ALIGNX program of Vector NTI Suite software (InforMax, Inc.). Two boxes
depicted in the map of amino acid sequence comparison represent the result of nsp1β and nsp2 protein N-terminal sequencing, which was determined by sequential Edman
degradation of 10 cycles for each viral protein. The upward and downward solid arrows point to the identiﬁed cleavage site of nsp1β/nsp2 and nsp1α/nsp1β, respectively. The
downward dashed arrow points to the predicted nsp1α/nsp1β cleavage site.
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tion of nsp1β generated a major signal of N-terminal sequence as
ATVYDIGRDA, which indicated the cleavage site between nsp1α/
nsp1β is at 180M↓A181 that is 14 amino acids downstream of the
predicted cleavage site at 166Q↓R167. Sequence analysis showed that
this cleavage site is conserved among different PRRSV Type II strains
(Fig. 2). While this manuscript was in preparation, a recent report
from Sun et al. (2009) identiﬁed crystal structure of nsp1α from
another Type II PRRSV strain, XH-GD, and the same nsp1α/nsp1β
cleavage site was determined in their study, which further con-
ﬁrmed that the actual cleavage site between nsp1α/nsp1β of Type II
PRRSV is at 180M↓A181. The corresponding cleavage site on Type I
PRRSV is at 180H↓S181 based on our sequence analysis (Fig. 2).
Whether this is the actual cleavage site needs to be further identiﬁed
in Type I PRRSV.
Subcellular localization of nsp1α and nsp1β
In EAV, nsp1 is expressed as a single protein that is actively
imported into the nucleus during the early stage of infection (Tijms et
al., 2002). To determine whether PRRSV nsp1 follows the same
cellular distribution pattern as that of EAV, we detected the
subcellular localization of nsp1α and nsp1β following the time course
of viral infection in MARC-145 cells. PRRSV SD23983 infected MARC-
145 cells were ﬁxed at 4, 6, 8, 10 and 12 hours post infection (hpi), and
stained with pAb-nsp1α or mAb-nsp1β antibodies (Fig. 3). Viral
protein speciﬁc ﬂuorescence can be detected as early as 6 hpi. All
PRRSV infected MARC-145 cells stained with anti-nsp1α or anti-
nsp1β antibody showed small dot-like bright punctate ﬂuorescent
foci, mostly concentrated on one side of the perinuclear region in the
cell cytoplasm. At 8 hpi, more intense and widespread ﬂuorescence
was observed for both proteins. Small punctate dot-like ﬂuorescent
staining patternwas observed for nsp1α, while the nsp1βwas stained
as bright ﬂuorescence mostly around the perinuclear region in
cytoplasm. At 10 hpi, we found that in some infected cells, nsp1α or
nsp1β localized into cell nucleus. To determine the percentage of cells
showing nuclear localization for nsp1α or nsp1β, we counted infected
cells in ﬁve ﬁelds of view under ﬂuorescent microscopy. For nsp1α,49% of infected cells showed nuclear localization, while more infected
cells (82%) showed nsp1β nuclear localization. At 12 hpi, almost all of
the infected cells (98%) showed nuclear localization for nsp1β, and
about 83% of infected cells showed nuclear localization for nsp1α.
Although both proteins were localized into the nucleus, the
localization pattern was quite different. For the nsp1α proteins that
retained in the cytoplasm, a scattered punctate dot-like ﬂuorescent
staining pattern was consistently observed. In contrast, nsp1β
expression showed a predominant nuclear and cytoplasmic staining
pattern, and the ﬂuorescent staining in the cytoplasm was diffused
through the cytoplasm.
The PRRSV nsp1α and nsp1β inhibit IFN-β activation
Previous studies showed that stimulation of MARC-145 cells by
exogenous double-stranded RNA resulted in signiﬁcant increases in
type I IFNmRNA expressionmeasured by real-time PCR. However, the
double-stranded RNA induction of type I IFN activation was
signiﬁcantly inhibited by exposure with PRRSV (Miller et al., 2004;
Luo et al., 2008). Our preliminary result showed that PRRSV nsp1 is
the main protein responsible for the inhibition of type 1 IFN
activation. Since the two auto-cleaved products of nsp1, nsp1α and
nsp1β, showed different subcellular localization patterns, we specu-
lated that these two proteins may inhibit the interferon response by
different mechanisms. In this study, we used an IFN-β promoter-
luciferase reporter system to determine which of the nsp1 auto-
cleaved products had an effect on IFN-β activation. Based on our N-
terminal protein sequencing analysis, the SD23983 virus nsp1
contains amino acid (AA) 1–383 of pp1a, nsp1α contains AA 1–180,
and nsp1β contains AA 181–383 of pp1a. Each of these protein-
encoding regions was cloned into the pCAGGS plasmid to generate
plasmids pCAGGS-nsp1, pCAGGS-nsp1α or pCAGGS-nsp1β. Protein
expression from these plasmids was conﬁrmed by IFA and Western
blot using pAb-nsp1α or mAb-nsp1β antibodies (Fig. 4). HEK293T
cells were co-transfected with each of these plasmids, a reporter
plasmid, p125-Luc that contains IFN-β promoter driving the expres-
sion of the luciferase reporter gene, and a Renilla luciferase expression
plasmid (pRL-SV40) to normalize expression levels of samples. As a
Fig. 3. Detection of nsp1α and nsp1β expression in virus-infected cells by indirect immunoﬂuorescence assay. MARC-145 cells were infected with PRRSV SD23983 and ﬁxed at 6, 8,
10 and 12 hpi. Cells were stained with a PRRSV protein speciﬁc primary antibody, pAb-nsp1α or mAb-nsp1β. FITC-conjugated goat anti-rabbit or anti-mouse antibody was used as
secondary antibody. Cell nucleus was stained with DAPI. Images were obtained by ﬂuorescence and phase-contrast microscopy using a 40× objective.
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co-transfect the cells with the reporter plasmid. Twenty-four hours
after transfection, cells were infected with SeV to induce luciferase
production. As shown in Fig. 5A, expression of either nsp1, nsp1α or
nsp1β strongly suppressed the expression of the IFN-β promoter-
driven luciferase. As we expected, the expression of inﬂuenza nsp1
also signiﬁcantly inhibited the luciferase synthesis. In contrast, a
strong reporter signal was observed in cells transfected with empty
plasmid, pCAGGS after infection by SeV.
The IFN-β promoter contains four positive regulatory domains
(PRDs), including the binding site for three different transcription
factors, interferon regulatory factor 3 (IRF3) (PRDs I and III), nuclear
factor-kB (NF-kB) (PRDII) and activating protein 1 (AP1) (PRD IV).
Maximal activation of the IFN-β promoter requires the binding of
transcription factors to the promoter and forming a so-called
enhanceosome on the PRDs (reviewed in Randall and Goodbourn,
2008). Previous study from Luo et al. (2008) demonstrated that PRRSV
suppresses IFN-β transcription by interfering with IRF3 activity but
not NF-kB and AP-1 activities, and its effect is through interrupting the
IPS-1 activity in the upstream of the IRF3 signaling pathway. We
investigated whether the PRRSV nsp1 associated proteins were the
proteins to block the IRF3 signaling pathway. Cells were cotransfected
with control plasmids or with plasmids expressing the PRRSV nsp1
proteins, the plasmid pRL-SV40, and a plasmid containing a ﬁreﬂy
luciferase gene under the control of a promoter with three IRF3
binding site (p55-CIB-Luc). As shown in Fig. 5B, after infection with
SeV, expression of either nsp1, nsp1α or nsp1β effectively blocked the
IRF3 dependent reporter gene expression.
We further determined whether the nsp1α or nsp1β was the
protein interfering with the IPS-1 activity. Since MDA5 or RIG-1 isassociated with IPS-1 caspase, we cotransfected cells with a plasmid
expressing MDA5, RIG-1 or IPS-1 protein, a plasmid expressing
individual PRRSV proteins, the plasmid pRL-SV40, and the p55-CIB-
Luc reporter plasmid. Previous study showed that overexpression of
RIG-1 or IPS-1 in cells led to activation of transcription from the
reporter plasmid (Childs et al., 2007). As shown in Figs. 5C–E, this
activity was suppressed by co-expression of the nsp1α or nsp1β. This
result suggests that PRRSV nsp1α and nsp1β may block the IPS-1
mediated IFN-β induction. Another possibility is that the downstream
portion of the signaling pathway was being blocked by these proteins.
TBK1 and IKKɛ are essential components downstream of RIG-1/IPS-1
caspase. We further tested the effect of PRRSV nsp1α and nsp1β on
the TBK1 and IKKɛ mediated IFN-β induction. Interestingly, either
nsp1α or nsp1β had the ability to suppress TBK1 and IKKɛ mediated
reporter gene expression (Figs. 5F–G). Both TBK1 and IKKɛ expression
should induce the activation of downstream transcription factor IRF3,
and overexpression of IRF3 itself should lead to activation of
transcription from the reporter plasmid. Again, nsp1α and nsp1β
blocked this effect (Fig. 5H). To conﬁrm that the PRRSV nsp1 proteins
were speciﬁcally affect on the IRF3 signaling pathway, activation of
NF-kB was examined using a reporter plasmid containing a ﬁreﬂy
luciferase gene under the control of an NF-kB responsive promoter
with two NF-kB binding sites (pNF-kB-Luc). HEK293T cells were co-
transfected with PRRSV nsp1 proteins expression plasmids, pNF-kB-
Luc (or p55-CIB-Luc), pRL-SV40, and a plasmid expressing TRIF, a key
component upstream of NF-kB and IRF3 signaling pathways. As we
expected, PRRSV nsp1 proteins did not affect the NF-kB dependent
reporter gene expression (Fig. 5I). In contrast, PRRSV nsp1 blocked the
IRF3 dependent reporter gene expression (Fig. 5J). Taken together
with the observations in Fig. 5, the data suggest that the PRRSV nsp1
Fig. 4. Identiﬁcation of nsp1α and nsp1β expression in transfected cells. HEK293T cells
were transfected with either control plasmid, pCAGGS or plasmids expressing PRRSV
nsp1 proteins, including pCAGGS, pCAGGS-nsp1α or pCAGGS-nsp1β. At 24 h post-
transfection, cells were ﬁxed for immunoﬂuorescence assay or harvested for Western
blot analysis. (A) Immunoﬂuorescent detection of nsp1α and nsp1β expression in
HEK293T cells. Cells were stained with a speciﬁc antibody as indicated at the bottom of
the picture, and DyLight 549-conjugated goat anti-rabbit or anti-mouse antibody was
used as the secondary antibody. Images were taken by ﬂuorescence and phase-contrast
microscopy using a 20× objective. (B)Western blotting analysis nsp1, nsp1α and nsp1β
expression in 293T cells. Membranes were probed with an nsp1 protein speciﬁc
antibody as indicated at the bottom of each membrane. Arrows point to the speciﬁc
PRRSV proteins.
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activation of IRF-3, possibly somewhere in the nucleus.
We further studied the activation and nuclear translocation of IRF3
in transfected cells. In response to cellular stimulation, the IRF3 is
activated by forming a phosphorylated dimer, which subsequently
translocates into the cell nucleus. Interestingly, when cells were
transfected with plasmid expressing PRRSV nsp1, nsp1α or nsp1β,
and infected with SeV as an activator of IRF3, we did not observe any
effect of PRRSV proteins on the phosphorylation and translocation of
IRF3 in transfected cells. These data suggest that the PRRSV nsp1
proteins have ability to block induction of IFN-β at a point
downstream of activation of IRF-3, since nsp1α and nsp1β expression
inhibit the activation of the IFN-β promoter but do not block the
activation of IRF-3. The observation that both nsp1α and nsp1β are
largely nuclear-located is in agreement with the hypothesis that
they may have a direct effect on the formation of the transcription
enhanceosome on the IFN-β promoter inside the nucleus.
The PRRSV nsp1β strongly inhibits gene expression from an ISRE
promoter
While our results showed that PRRSV nsp1α and nsp1β strongly
inhibit IFN-β synthesis, we further tested whether PRRSV nsp1α ornsp1β could inhibit the cellular response to interferon (interferon
signaling). When interferon binds to a receptor, the signaling pro-
cess through the JAK-STAT pathway results the activation of geneswith
an ISRE promoter. To determine whether PRRSV nsp1α or nsp1β has
ability to inhibit the activation of genes with an ISRE promoter, cells
were co-transfected with a plasmid expressing individual PRRSV
proteins (nsp1, nsp1α or nsp1β), and a reporter plasmid expressing
luciferase under the control of the ISRE promoter. As shown in Fig. 6,
after stimulating with SeV, IFN-α or IFN-β, the nsp1β and nsp1
signiﬁcantly inhibit the expression of luciferase from the ISRE
promoter, which indicates that nsp1β not only inhibits interferon
synthesis, but also inhibits interferon signaling. Some level of inhibition
on luciferase expression was observed in cells transfected with nsp1α,
but the luciferase expression level is consistently higher in nsp1α
transfected cells than those cells transfected with nsp1β.
The PRRSV nsp1β but not nsp1α inhibit the translocation of STAT1
One of the mechanisms of viral proteins inhibiting interferon
signaling is to interfere with the function of a key transcription factor,
STAT1. Upon interferon signaling, the STAT1 is phosphorylated and
translocated from the cell cytoplasm into the nucleus, where it binds
to the ISRE promoter to activate the expression of ISG genes. The
STAT1 translocation was analyzed in cells cotransfected with a
plasmid expression of STAT1-GFP fusion protein, and a plasmid
expression of nsp1α or nsp1β. Twenty-four hours post transfection,
cells were stimulatedwith IFN-β. After 2 h, the STAT1-GFP localization
was observed by ﬂuorescent microscopy. In cells transfected with
nsp1α or negative control empty plasmid, treatment of IFN-β caused
STAT1-GFP to translocate into the nucleus (Fig. 7A). Interestingly, in
cells transfected with nsp1β, STAT1-GFP is retained in the cell
cytoplasm after treatment with IFN-β (Fig. 7A). This result indicates
that PRRSV nsp1β has the ability to inhibit the translocation of STAT1-
GFP into the cell nucleus.
To further analyze the mechanism of STAT1 activation, phosphor-
ylation of the STAT1 was determined in cells cotransfected with
plasmids expressing PRRSV proteins and STAT1. Transfected cells
were treated with IFN-β for 2 h. Cells were harvested and analyzed by
Western blot for STAT1 phosphorylation using an antibody speciﬁc to
STAT1 or the phosphorylated form of STAT1. The Western blot result
showed that similar levels of total STAT1 protein were expressed in
cells transfected with different PRRSV proteins. However, the
phospho-STAT1 was barely detected in cells transfected with nsp1β
(Fig. 7B). These results indicate that nsp1β inhibits phosphorylation
and activation of the STAT1 in the IFN-β signaling pathway.
Discussion
Since the ﬁrst isolation of PRRSV, a wealth of information has been
produced on the structural proteins. However, little is known about
the structure and function of PRRSV nonstructural proteins (nsp),
which account for 75% of the viral genome. Individual PRRSV nsp
proteolytic processing products were mainly predicted based on the
homologous genome sequence comparison between PRRSV and EAV
(Snijder and Meulenberg, 1998; Allende et al., 1999; Nelsen et al.,
1999; Ziebuhr et al., 2000). This study is the ﬁrst to identify and
characterize individual nsp processing products in PRRSV-infected
cells. Our results demonstrated the actual existence of two auto-
cleaved products of nsp1, nsp1α and nsp1β in PRRSV infected cells.
This result is consistent with previous ﬁndings in the in vitro system
(den Boon et al., 1995; Johnson et al., 2007). More importantly, we
identiﬁed the actual cleavage site between nsp1α/nsp1β and nsp1β/
nsp2 of Type II PRRSV. This data is further supported by the recent
identiﬁcation of the crystal structure of nsp1α (Sun et al., 2009).
Identiﬁcation of the actual cleavage sites between nsp1α/nsp1β and
nsp1β/nsp2 has clariﬁed the confusion previously reported in the
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Fig. 6. PRRSV nsp1 proteins inhibit expression from an ISRE promoter. HEK293T cells
were cotransfected with pISRE-luc, pRL-SV40 and pCAGGS expressing nsp1 proteins or
pCAGGS empty vector (P) for 20 h. Cells were then infected with Sendai virus (A) or
treated with IFN-α (B) and IFN-β (C) for 20 h. The cells were harvested and measured
for ﬁreﬂy and Renilla luciferase activities. Relative luciferase activity is deﬁned as a ratio
of ﬁreﬂy luciferase reporter activity to Renilla luciferase activity. Each data point shown
represents a mean value from three experiments. Error bars show standard deviations
of the normalized data.
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of the dynamic movement of nsp1 proteins in PRRSV infected cells
revealed the interesting localization patterns of nsp1α and nsp1β. Our
results showed that during the early stage of infection (6 and 8 hpi),
the nsp1α and nsp1β were mainly retained in the cell cytoplasm. At
this stage, especially at 6 hpi, we observed that both nsp1α and nsp1β
co-localized with most of the PRRSV ORF1a encoded nsps, including
nsp2, nsp4, nsp7 and nsp8, into a perinuclear site as a distinct
ﬂuorescent spot (data not shown), which is assumed to be the site ofFig. 5. PRRSV nsp1 proteins inhibit IFN-β production. (A, B) HEK293T cells cultured in 24
expressing inﬂuenza virus NS1, or pCAGGS empty vector (P), pRL-SV40, and a luciferase re
infected with Sendai virus (SeV) for 16 h to stimulate the production of interferon. (C–H, J)
pEFneo-MDA5 (D), pEGFP-IPS-1 (E), pEFneo-TBK1 (F), pEFneo-IKKɛ (G), or pCAGGS-IRF3 (
pCIB-55 plasmid for 20–24 h. (I) HEK293T cells were cotransfected with pNF-kB-luc, pcDNA3
20 h. Cells were harvested and measured for ﬁreﬂy and Renilla luciferase activities. Relativ
luciferase activity. Each data point shown represents a mean value from three experimentsthe replication complex (Snijder and Meulenberg, 1998). At the later
stages of infection (10 and 12 hpi), these two proteins are mainly
localized into the cell nucleus. One simple explanation of this pheno-
menon is that during the early stage of infection, nsp1 is synthesized
as part of a large pp1a polyprotein staying in the cytoplasm, and the
subunits are subsequently liberated as individual proteins capable of
translocating to the nucleus. Another possibility is that there may be
two forms of nsp1α (and nsp1β): The cytoplasmic form participates
in the replication complex formation, and the nuclear form interacts
with the host protein(s). We have noticed that certain lots of rabbit
anti-nsp1α serum stained nsp1α predominantly in cytoplasm by
immunoﬂuorescence assay.
Another important ﬁnding from this study is that PRRSV nsp1α and
nsp1β proteinswere determined to be involved in blockage of the type I
interferon synthesis and signalingpathway. Aswe indicated above, each
of these two proteins encode a papain-like cysteine protease (PCP)
(nsp1α encodes PCPα; nsp1β encodes PCPβ). Thus, the nsp1α and
nsp1β aremultifunctional proteins. Theynot only play an important role
in the proteolytic processing of replicase polyproteins, but are also
involved in suppressing of the host innate antiviral response. Previous
studies showed that proteases of positive-stranded RNA viruses are
commonly multifunctional, and they are actively involved in antago-
nizing the host cell antiviral response. For example, hepatitis C virus NS3
and NS4A proteins associated to form an active enzyme, which
possesses RNA helicase and serine protease activities in the polyprotein
processing and HCV replication. The NS3/4A also has an ability to block
the type I interferon gene expression by targeting the toll-like receptor 3
adaptor protein TRIF and interferingwith theRIG-I-dependent signaling
pathway (Karayiannis, 2005; Li et al., 2005). The N (pro) of pestiviruses
is the ﬁrst protein encoded by the single large open reading frame of the
positive-sense RNA genome. It is a cysteine protease, which has an
autoproteolytic activity to cleave itself off from the polyprotein. The N
(pro) subverts host cell antiviral responses by targeting IRF3 and
promoting its proteasomal degradation, a process that is independent of
the proteolytic activity of N (pro) (Hilton et al., 2006; Bauhofer et al.,
2007; Chen et al., 2007; Seago et al., 2007).
It remains to be determined where in the IFN induction path-
way PRRSV nsp1 proteins (α and β) are having their effect.
Overexpression of components of the pathway by which IRF-3 is
activated in response to cytoplasmic dsRNA stimulation showed that
PRRSV nsp1 proteins act downstream of all of them. We hypothesize
that the PRRSV nsp1 proteins may be acting downstream of IRF-3
activation, which may have a direct effect on the formation of the
transcription enhanceosome on the IFN-β promoter inside the
nucleus. This hypothesis is supported by our observation that the
nsp1α and nsp1β were predominantly localized into the cell
nucleus during the later time of infection, and by the fact that
IRF3 appears to be activated and transported into the nucleus
normally after SeV infection of nsp1, nsp1α or nsp1β transfected
cells. An example of this case is the Thogoto virus ML protein. The
ML protein prevents the IRF3 dimerization and binding to c-AMP
response element binding protein (CBP), which in turn prevents the
formation of the transcription enhanceosome on the IFN-β promoter
(Jennings et al., 2005). Further studies are required to map the exact
point(s) on the IFN induction pathway at which PRRSV nsp1
proteins act. It will be interesting to determine the requirement for
nuclear localization of the PRRSV nsp1 proteins, which relates to
their interferon antagonist function. PRRSV nsp1 does not contain
the traditional nuclear localization signal (NLS), a similar feature as-well plates were cotransfected with a plasmid expressing nsp1 proteins, a plasmid
porter plasmid p125-Luc (A) or pCIB-55-Luc (B). At 20 h post transfection, cells were
HEK293T cells in 24-well plates were cotransfected with the plasmid pEFneo-RIG-I (C),
H), or pcDNA3-TRIF (J), along with pRL-SV40, pCAGGS expressing nsp1 proteins, and
-TRIF, pRL-SV40 and pCAGGS expressing nsp1 proteins or pCAGGS empty vector (P) for
e luciferase activity is deﬁned as a ratio of ﬁreﬂy luciferase reporter activity to Renilla
. Error bars show standard deviations of the normalized data.
Fig. 7. Analysis of PRRSV nsp1 protein's effect on STAT1 translocation and phosphorylation. (A) HEK293T Cells were transfected with the indicated plasmid and STAT1-GFP for 20 h
and then treated with IFN-β for 2 h. Cells were ﬁxed and stained with pAb-nsp1α or mAb-nsp1β. DyLight 549-conjugated goat anti-rabbit or anti-mouse antibody (red ﬂuorescence)
was used as the secondary antibody. Cell nucleus was stained with DAPI (blue ﬂuorescence). The protein localization was analyzed by ﬂuorescence phase-contrast microscopy using
a 40× objective. (B) HEK293T cells were transfected with the indicated plasmid for 24 h and then treated with IFN-β for 2 h. Cells were harvested, and lysates were analyzed by
Western blot using antibodies recognizing total and phosphorylated forms of STAT1, pAb-nsp1α, mAb-nsp1β and anti-β-tubulin as a loading control.
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95Z. Chen et al. / Virology 398 (2010) 87–97the EAV nsp1 (Tijms et al., 2002), which suggests that these
proteins may be bound with cellular protein(s) and shuttled into
the nucleus.
Besides their inhibition in IFN-β synthesis, the PRRSV nsp1,
especially nsp1β, was determined to be able to inhibit interferon
signaling pathway. The nsp1β demonstrated strong inhibition effect
on the expression of reporter gene from an ISRE promoter after IFN-β
stimulation. Its action on this pathway appears on the blockage of the
STAT1 phosphorylation and preventing the STAT1 nuclear localiza-
tion. Limited inhibition effect of nsp1α on this pathway was observed.
Under natural infection, both nsp1α and nsp1β exist in the infected
cells. It was consistently shown that cells transfected with nsp1
(nsp1α plus nsp1β) had lower levels of luciferase reporter signal than
those cells transfected with nsp1β or nsp1α alone. Based on our
results, it seems that the sum of effect by nsp1α and nsp1β alone are
equivalent to the effect of nsp1. Another interesting observation is
that nsp1β alone appears to suppress STAT1 phosphorylation,
whereas nsp1α alone appears to lead to disappearance of STAT1
from the cytoplasm. Fig. 7A shows nsp1α concentrated in dots on the
edge of nuclei and almost no cytoplasmic STAT1, whereas nsp1β does
not show intense perinuclear ﬂuorescence and has no apparent effect
on the cytoplasmic ﬂuorescence signal of STAT1, only on exclusion of
STAT1 from nuclei. The detailed mechanism involved in this pathway
needs to be further elucidated in the future. The fact that PRRSV nsp1
is also a functional antagonist in IFN signaling pathway opens a wide
range of possibilities towards analyzing the pathways involved. There
is no previous evidence for the ability of arteriviruses to interfere with
IFN signaling pathways. In contrast, coronaviruses, a family of viruses
closely related to arteriviruses, have been well studied on their
function of antagonizing interferon signaling. The SARS-CoV nsp1 not
only inhibits IFN production, but also inhibits IFN-dependent
signaling pathways (Wathelet et al., 2007). This study demonstrated
an initial step toward understanding the effect of PRRSV proteins on
the IFN signaling pathway. Future studies are required to elucidate the
detailed mechanisms that PRRSV involve in this pathway. It will be
interesting to determine the effect of PRRSV nsp1 proteins on other
components of IFN signaling.
Like the SARS-CoV nsp1, PRRSV nsp1 proteins are able to target
multiple steps of the interferon response. Viral proteins that target
multiple steps of interferon activation increase the likelihood that the
virus can completely inhibit the interferon response. The observation
that nsp1a and nsp1β can act independently to antagonize the host
cell interferon response does not exclude the possibility that
additional PRRSV proteins might exert a similar function or act
synergistically to antagonize interferon activity. Preliminary studies
from our laboratory and others suggest that PRRSV most likely
expresses a number of proteins to suppress host antiviral innate
immune response. A recent study from Frias-Staheli et al. (2007)
reported that the cysteine protease encoded by PRRSV nsp2 is capable
of inhibiting Ub- and ISG15-dependent innate immune responses.
Under natural viral infection conditions, the IFN antagonist activity
involves entire viral proteins that function simultaneously. The
function of a single protein may be enhanced or diminished in the
context of the multi-protein system. Therefore, future studies are
needed to identify the other PRRSV proteins that function as
interferon antagonists, and study the synergist effect of the PRRSV
nsp1 proteins with other proteins. It is possible that other PRRSV
proteins target different parts of innate immune response from those
of nsp1 proteins, such as SARS-CoV N, ORF3b and ORF6, which interact
in different steps of the interferon synthesis and signaling pathway
(Kopecky-Bromberg et al., 2007). Viruses encoding multiple proteins
that are able to target more than one step of the interferon response
are most likely to cause a severe inhibition of interferon. The data
from this study demonstrated that PRRSV nsp1 proteins, especially
nsp1β, are virulence factors that can inhibit multiple steps of the host
interferon response. Their synergistic effect with other PRRSVproteins, such as nsp2, during the course of infection could be able
to shut down the host cell innate immune response completely. This
may explain why the induction of interferon and some innate
cytokines is inhibited during PRRSV infection.
In summary, PRRSV has evolved strategies to ﬁght the interferon
system by blocking the IFN synthesis and signaling. Results from this
study demonstrated that the PRRSV nsp1α and nsp1β are key players
in this context. This work provides further insight into the immune
evasion strategies utilized by PRRSV. Identiﬁcation of the speciﬁc viral
protein(s) responsible for the antagonizing of IFN response is an
important initial step in the development of vaccine and therapeutics
aimed at disrupting this critical aspect of viral pathogenesis. Future
study should be directed towards identifying the region or amino
acids on the PRRSV nsp1 that can be altered in order to remove (or
decrease) the interferon antagonist function.
Materials and methods
Cells and viruses
HEK293T cells and MARC-145 cells (a PRRSV permissive cell line)
were cultured in modiﬁed Eagle medium (Invitrogen) containing 10%
fetal bovine serum. North American Type II PRRSV isolate SD23983
was used to infect MARC-145 cells for subsequent experiments. The
Sendai virus (SeV) Cantell strain was grown in embryonated chicken
eggs. Virus titer was determined by hemagglutination assay using
chicken red blood cells as described previously (Yonemitsu and
Kaneda, 1999).
Monoclonal and polyclonal antibody production
For production of antibodies to nsp1α, nsp1β, nsp1, and nsp2,
recombinant proteins were expressed in E. coli and puriﬁed as
described previously (Johnson et al., 2007; Brown et al., 2009).
Monoclonal antibodies (mAb-nsp1β, mAb-nsp2) were produced by
immunizing BALB/c mice with 50 μg of nsp1β or nsp2 antigen mixed
with Freund's incomplete adjuvant at 2-week intervals for 8 weeks.
Mouse splenocytes were fused with NS-1 myeloma cells. An
immunoﬂuorescent assay was used to screen for speciﬁc anti-PRRSV
mAbs as we described previously (Fang et al., 2006). Hybridomas
secreting PRRSV-speciﬁc mAbs were sub-cloned, and mAbs were
obtained from cell culture supernatant or mouse ascites ﬂuid. MAbs
were isotyped using an IsoStrip Kit (Serotec, Inc.) following the
manufacturer's instructions. Polyclonal antibodies (pAb-nsp1, pAb-
nsp1α) were raised in New Zealand white rabbits by using
recombinant proteins nsp1 and nsp1α. For primary immunizations,
100 μg of nsp1 or nsp1α antigen was mixed with an equal volume of
Freund's incomplete adjuvant, and injected subcutaneously at six
different locations. Rabbits were boosted twice at 2-week intervals.
Indirect immunoﬂuorescence assay (IFA)
Virus infected or plasmid DNA transfected cells were ﬁxed with
3.7% formaldehyde in PBS (pH 7.4) for 10min, and then permeabilized
with 0.1% Triton X-100 plus 2% BSA in PBS for 30 min at room
temperature. Fixed cells were incubated for 1 h with the primary
antibodies (mouse ascites at dilution of 1:100 or rabbit polyclonal
antibody at dilution of 1:50) at 37 °C. FITC- or DyLight 549-conjugated
goat anti-mouse or anti-rabbit antibody (1:100 dilution; ICN
Biomedicals, Inc.; KPL, Inc.) was used as the secondary antibody.
Nuclear staining with 4, 6-diamidino-2-phenylindole-dihydrochlor-
ide (DAPI) was performed as recommended by the manufacturer
(Molecular Probes). Cell preparations were imaged under an inverted
ﬂuorescent microscope (Olympus). Images were taken with a 40× or
20× objective. Images were processed with DP-BSW (Version 03.02,
Olympus) and Adobe Photoshop 6.0 software.
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Virus infected or plasmid DNA transfected cells were harvested
and lysed in lyses buffer (1% NP-40, 0.5% deoxycholate, 0.1% sodium
dodecyl sulfate [SDS], and 1 mM EDTA in PBS) supplemented with
protease inhibitor cocktail (Roche). Lysates were frozen at −80 °C,
thawed, and centrifuged to remove the insoluble pellet. The protein
concentration in the supernatant was determined by a Bradford assay
(Bio-Rad). Equal amounts of proteins were separated by electropho-
resis on a polyacrylamide gel. The separated proteins were blotted
onto a nitrocellulosemembrane as we described previously (Wu et al.,
2001). After blotting, membranes were blocked with 5% nonfat dry
milk in PBST (0.05% Tween 20 in 1× PBS). The membrane was then
incubated with primary antibodies (1:1000 dilution of mAb; 1:200
dilution for pAb) for 1 h at room temperature. For detecting the
expression of PRRSV proteins, rabbit polyclonal antibodies against
nsp1 or nsp1α, or mouse monoclonal antibody against nsp1β were
used. For detection of STAT1 expression, a nitrocellulose membrane
was probed with rabbit anti-total STAT1, or rabbit anti-phospho-
STAT1 recognizing phosphorylation at tyrosine 701 (Santa Cruz
Biotechnology). The mouse anti-β-tubulin (Lamda Biotech) antibody
was used as a control. After incubation with primary antibody, the
membranewas washedwith PBST. The secondary antibody, goat anti-
mouse or anti-rabbit (Kirkegaard & Perry Laboratories, Gaithersburg,
MD), was added and incubated for 60 min. The membrane was
developed using the method we described previously (Wu et al.,
2001).
Protein N-terminal sequencing
The PRRSV nsp1β and nsp2 protein N-terminal sequencing was
carried out at the Harvard Microchemistry and Proteomics Analysis
Facility (Cambridge, MA). The PRRSV proteins were immunoprecipi-
tated from the SD23983 virus infected cell lysate using anti-nsp1β and
anti-nsp2 monoclonal antibodies. The immunoprecipitated PRRSV
proteins were separated by electrophoresis on a polyacrylamide gel.
After gel electrophoresis, gels were soaked in transfer buffer (10 mM
3-[cyclohexylamino]-1-propanesulfonic acid, 10% methanol, pH 11.0)
for 5 min. At the same time, the PVDF membrane was rinsed with
100% methanol and stored in transfer buffer. The gel, sandwiched
between a sheet of PVDF membrane and blotting papers, was
assembled into a blotting apparatus for 1 h at 0.24 A in transfer
buffer. The transferred PVDFmembranewaswashed in deionized H2O
and stained with 0.5% Ponceau S in 1% acetic acid. The membrane was
ﬁnally rinsed in deionized H2O and air dried. Corresponding protein
bands were cut from the membrane and were subjected to automatic
sequential Edman degradation for 10 cycles using the PE/ABD Procise
494 HT Protein Sequencing System.
Plasmids
The nsp1α, nsp1β and nsp1 regions of SD23983 were RT-PCR
ampliﬁed from genomic RNA, and PCR products were cloned into a
eukaryotic expression vector, pCAGGS [a generous gift fromDr. Adolfo
Garcia-Sastre (Muñoz-Jordan et al., 2003)], designated as pCAGGS-
nsp1α, pCAGGS-nsp1β and pCAGGS-nsp1. Reporter plasmids expres-
sing the ﬁreﬂy luciferase under the control of either the IFN-β
promoter (p125-Luc) or an artiﬁcial promoter containing three IRF3
binding sites (p55-CIB-Luc) were kindly provided by Dr. Takashi
Fujita (Yoneyama et al., 1996). The pNF-kB-Luc or pISRE-Luc reporter
plasmids expressing the ﬁreﬂy luciferase under the control of a
promoter with NF-kB-response element or the interferon-stimulated
response element (ISRE) was purchased from Stratagene (La Jolla,
CA). The pRL-SV40 plasmid that expresses a Renilla luciferase under
the control of a simian virus (SV) 40 promoter was purchased from
Promega (Madison, WI). The pEFneo-RIG-I, pEFneo-MDA5, pEFneo-TBK1, and pEFneo-IKKɛ were kindly provided by Dr. Bin Gotoh
(Komatsu et al., 2007). The pcDNA3-TRIF was purchased from
Addgene. The pEGFP-STAT1 and pN1-IPS-1 plasmids were con-
structed by PCR ampliﬁcation of STAT1 and IPS-1 genes from the
full-length cDNA clones (ATCC IMAGE clone ID 3627218 and ID
5751684, respectively), and subsequently cloned into pEGFP-N1
vector. The pEGFP-IRF3 plasmid was kindly provided by Dr. John
Hiscott (Hiscott et al., 1999), and was used as a template for cloning of
IRF3 gene into pCAGGS vector to construct pCAGGS-IRF3 plasmid. The
pCAGGS-NS1 plasmid was constructed by RT-PCR ampliﬁcation of
NS1 gene from inﬂuenza A/swine/Texas/4199-2/98 (TX/98, H3N2
subtype, a generous gift from Dr. Jurgen Richt; Solórzano et al., 2005),
and subsequently cloned into pCAGGS vector.Cell transfection and luciferase reporter assay
HEK293T cells were seeded in 24-well plates and transfected with
various combinations of plasmids DNA: the pEFneo-RIG-I, pEFneo-
MDA5, pN1-IPS-1, pEFneo-TBK1, pEFneo-IKKɛ, pcDNA3-TRIF, or
pCAGGS-IRF3 was mixed with a plasmid encoding the PRRSV protein
(or empty pCAGGS), luciferase reporter plasmid and pSV40-RL.
Transfection was performed using HD-FuGENE 6 transfection reagent
followed the manufacturer's instruction (Roche Molecular Biochem-
icals). For the Sendai virus or IFN stimulation, HEK293T cells were
transfected with a plasmid encoding the PRRSV proteins (or empty
pCAGGS, pCAGGS-NS1), reporter plasmids and pSV40-RL. At 20
h post-transfection, cells were infected with Sendai virus at 5000
HA unit/0.5 ml/well for 12–16 h, or induced by treatment with
2000 IU/0.5 ml/well of IFNα or IFN β for 16 h. Cells were harvested at
the indicated time points. Cell lysates were prepared and subjected to
reporter gene assay using the dual luciferase reporter system
(Promega) according to manufacturer's instruction. Fireﬂy and Re-
nilla luciferase activities were measured in a luminometer (Bethold).
Values for each sample were normalized using the Renilla luciferase
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